{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T09:10:55Z","timestamp":1777972255451,"version":"3.51.4"},"update-to":[{"DOI":"10.1371\/journal.pmed.1003851","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T00:00:00Z","timestamp":1638921600000}}],"reference-count":61,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T00:00:00Z","timestamp":1637539200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"abstract":"<jats:sec id=\"sec001\"><jats:title>Background<\/jats:title><jats:p>The prevalence of depression and the exposure to antidepressants are high among women of reproductive age and during pregnancy. Duloxetine is a selective serotonin-norepinephrine reuptake inhibitor (SNRI) approved in the United States and Europe in 2004 for the treatment of depression. Fetal safety of duloxetine is not well established. The present study evaluates the association of exposure to duloxetine during pregnancy and the risk of major and minor congenital malformations and the risk of stillbirths.<\/jats:p><\/jats:sec><jats:sec id=\"sec002\"><jats:title>Methods and findings<\/jats:title><jats:p>A population-based observational study was conducted based on data from registers in Sweden and Denmark. All registered births and stillbirths in the medical birth registers between 2004 and 2016 were included. Malformation diagnoses were identified up to 1 year after birth. Logistic regression analyses were used. Potential confounding was addressed through multiple regression, propensity score (PS) matching, and sensitivity analyses. Confounder variables included sociodemographic information (income, education, age, year of birth, and country), comorbidity and comedication, previous psychiatric contacts, and birth-related information (smoking during pregnancy and previous spontaneous abortions and stillbirths).<\/jats:p><jats:p>Duloxetine-exposed women were compared with 4 comparators: (1) duloxetine-nonexposed women; (2) selective serotonin reuptake inhibitor (SSRI)-exposed women; (3) venlafaxine-exposed women; and (4) women exposed to duloxetine prior to, but not during, pregnancy. Exposure was defined as redemption of a prescription during the first trimester and throughout pregnancy for the analyses of malformations and stillbirths, respectively. Outcomes were major and minor malformations and stillbirths gathered from the national patient registers. The cohorts consisted of more than 2 million births with 1,512 duloxetine-exposed pregnancies. No increased risk for major malformations, minor malformations, or stillbirth was found across comparison groups in adjusted and PS-matched analyses. Duloxetine-exposed versus duloxetine-nonexposed PS-matched analyses showed odds ratio (OR) 0.98 (95% confidence interval [CI] 0.74 to 1.30,<jats:italic>p<\/jats:italic>= 0.909) for major malformations, OR 1.09 (95% CI 0.82 to 1.45,<jats:italic>p<\/jats:italic>= 0.570) for minor malformation, and 1.18 (95% CI 0.43 to 3.19,<jats:italic>p<\/jats:italic>= 0.749) for stillbirths. For the individual malformation subtypes, some findings were statistically significant but were associated with large statistical uncertainty due to the extremely small number of events. The main limitations for the study were that the indication for duloxetine and a direct measurement of depression severity were not available to include as covariates.<\/jats:p><\/jats:sec><jats:sec id=\"sec003\"><jats:title>Conclusions<\/jats:title><jats:p>Based on this observational register-based nationwide study with data from Sweden and Denmark, no increased risk of major or minor congenital malformations or stillbirth was associated with exposure to duloxetine during pregnancy.<\/jats:p><\/jats:sec>","DOI":"10.1371\/journal.pmed.1003851","type":"journal-article","created":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T18:36:02Z","timestamp":1637606162000},"page":"e1003851","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["Exposure to duloxetine during pregnancy and risk of congenital malformations and stillbirth: A nationwide cohort study in Denmark and Sweden"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7954-9255","authenticated-orcid":true,"given":"Mikkel Z\u00f6llner","family":"Ankarfeldt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7323-2548","authenticated-orcid":true,"given":"Janne","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon Tr\u00e6rup","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3430-3651","authenticated-orcid":true,"given":"Stephen Paul","family":"Motsko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Fast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone M\u00f8ller","family":"Hede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3777-147X","authenticated-orcid":true,"given":"Espen","family":"Jimenez-Solem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2021,11,22]]},"reference":[{"issue":"7307","key":"pmed.1003851.ref001","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/bmj.323.7307.257","article-title":"Cohort study of depressed mood during pregnancy and after childbirth","volume":"323","author":"J Evans","year":"2001","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"2","key":"pmed.1003851.ref002","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1037\/0022-006X.57.2.269","article-title":"Prevalence rates and demographic characteristics associated with depression in pregnancy and the postpartum","volume":"57","author":"IH Gotlib","year":"1989","journal-title":"J Consult Clin Psychol"},{"issue":"4","key":"pmed.1003851.ref003","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1097\/01.AOG.0000116689.75396.5f","article-title":"Prevalence of depression during pregnancy: systematic review 1","volume":"103","author":"HA Bennett","year":"2004","journal-title":"Obstet Gynecol"},{"issue":"6","key":"pmed.1003851.ref004","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.encep.2010.02.004","article-title":"Antepartum depression: Prevalence, diagnosis and treatment","volume":"36","author":"O Chatillon","year":"2010","journal-title":"Enc\u00e9phale"},{"issue":"11","key":"pmed.1003851.ref005","doi-asserted-by":"crossref","first-page":"e01441","DOI":"10.1002\/brb3.1441","article-title":"Trend of antidepressants before, during, and after pregnancy across two decades\u2014A population-based study","volume":"9","author":"Y Sun","year":"2019","journal-title":"Brain Behav"},{"key":"pmed.1003851.ref006","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1056\/NEJMc060602","article-title":"Selective serotonin-reuptake inhibitors and persistent pulmonary hypertension of the newborn","volume":"354","author":"J Reefhuis","year":"2006","journal-title":"N Engl J Med"},{"key":"pmed.1003851.ref007","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ajog.2007.01.033","article-title":"Increasing use of antidepressants in pregnancy","volume":"196","author":"WO Cooper","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"pmed.1003851.ref008","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ajog.2007.07.036","article-title":"Use of antidepressant medications during pregnancy: a multisite study","volume":"198","author":"SE Andrade","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"pmed.1003851.ref009","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/jama.287.3.337","article-title":"Recent patterns of medication use in the ambulatory adult population of the United States: The Slone survey","volume":"287","author":"DW Kaufman","year":"2002","journal-title":"JAMA"},{"issue":"5","key":"pmed.1003851.ref010","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1089\/jwh.2005.14.401","article-title":"Correlates of prescription drug use during pregnancy","volume":"14","author":"EH Riley","year":"2005","journal-title":"J Womens Health"},{"issue":"1","key":"pmed.1003851.ref011","doi-asserted-by":"crossref","first-page":"51.e1","DOI":"10.1016\/j.ajog.2011.02.029","article-title":"Medication use during pregnancy, with particular focus on prescription drugs: 1976\u20132008","volume":"205","author":"AA Mitchell","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"pmed.1003851.ref012","doi-asserted-by":"crossref","first-page":"e63034","DOI":"10.1371\/journal.pone.0063034","article-title":"Prevalence of antidepressant use during pregnancy in Denmark, a nation-wide cohort study","volume":"8","author":"E Jimenez-Solem","year":"2013","journal-title":"PLoS ONE"},{"issue":"2","key":"pmed.1003851.ref013","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ajog.2004.04.025","article-title":"Prescription drug use in pregnancy","volume":"191","author":"SE Andrade","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"pmed.1003851.ref014","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.genhosppsych.2012.12.010","article-title":"National trends in antidepressant medication treatment among publicly insured pregnant women","volume":"35","author":"KF Huybrechts","year":"2013","journal-title":"Gen Hosp Psychiatry"},{"issue":"5","key":"pmed.1003851.ref015","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/hup.696","article-title":"Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo-controlled clinical trials","volume":"20","author":"JI Hudson","year":"2005","journal-title":"Hum Psychopharmacol"},{"issue":"26","key":"pmed.1003851.ref016","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1056\/NEJMoa067407","article-title":"First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects","volume":"356","author":"C Louik","year":"2007","journal-title":"N Engl J Med"},{"issue":"26","key":"pmed.1003851.ref017","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1056\/NEJMoa066584","article-title":"Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects","volume":"356","author":"S Alwan","year":"2007","journal-title":"N Engl J Med"},{"issue":"1","key":"pmed.1003851.ref018","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/bdrb.20099","article-title":"First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage","volume":"80","author":"A Berard","year":"2007","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"issue":"10","key":"pmed.1003851.ref019","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/pds.1463","article-title":"Paroxetine in the first trimester and the prevalence of congenital malformations","volume":"16","author":"JA Cole","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"pmed.1003851.ref020","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/01.ede.0000239581.76793.ae","article-title":"Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations","volume":"17","author":"P Wogelius","year":"2006","journal-title":"Epidemiology"},{"issue":"3","key":"pmed.1003851.ref021","doi-asserted-by":"crossref","first-page":"e001148","DOI":"10.1136\/bmjopen-2012-001148","article-title":"Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort study","volume":"2","author":"E Jimenez-Solem","year":"2012","journal-title":"BMJ Open"},{"issue":"1","key":"pmed.1003851.ref022","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/jama.2012.153812","article-title":"Selective serotonin reuptake inhibitors during pregnancy and risk of stillbirth and infant mortality","volume":"309","author":"O Stephansson","year":"2013","journal-title":"JAMA"},{"issue":"3","key":"pmed.1003851.ref023","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1176\/appi.ajp.2012.11081251","article-title":"SSRI Use During Pregnancy and Risk of Stillbirth and Neonatal Mortality","volume":"170","author":"E Jimenez-Solem","year":"2013","journal-title":"Am J Psychiatry"},{"issue":"Suppl 1","key":"pmed.1003851.ref024","first-page":"7","article-title":"Single-Action Versus Dual-Action Antidepressants","volume":"6","author":"R Jain","year":"2004","journal-title":"Prim Care Companion J Clin Psychiatry"},{"issue":"4","key":"pmed.1003851.ref025","doi-asserted-by":"crossref","first-page":"413","DOI":"10.7150\/ijms.5213","article-title":"Duloxetine and pregnancy outcomes: safety surveillance findings","volume":"10","author":"SL Hoog","year":"2013","journal-title":"Int J Med Sci"},{"issue":"5","key":"pmed.1003851.ref026","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1176\/appi.ajp.2008.07071194","article-title":"Poor neonatal adaptation after in utero exposure to duloxetine","volume":"165","author":"R Eyal","year":"2008","journal-title":"Am J Psychiatry"},{"issue":"10","key":"pmed.1003851.ref027","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1177\/0009922812450509","article-title":"Duloxetine withdrawal syndrome in a newborn","volume":"52","author":"NA Abdy","year":"2013","journal-title":"Clin Pediatr (Phila)"},{"issue":"10","key":"pmed.1003851.ref028","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1176\/appi.ajp.158.10.1728","article-title":"Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study","volume":"158","author":"A Einarson","year":"2001","journal-title":"Am J Psychiatry"},{"issue":"10","key":"pmed.1003851.ref029","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3390\/ph6101221","article-title":"The use of central nervous system active drugs during pregnancy","volume":"6","author":"B Kallen","year":"2013","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"pmed.1003851.ref030","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/bdrb.20144","article-title":"Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data","volume":"83","author":"TF Oberlander","year":"2008","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"issue":"11","key":"pmed.1003851.ref031","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.4088\/JCP.12l08013","article-title":"Rates of major malformations in infants following exposure to duloxetine during pregnancy: a preliminary report","volume":"73","author":"A Einarson","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"pmed.1003851.ref032","doi-asserted-by":"crossref","first-page":"m237","DOI":"10.1136\/bmj.m237","article-title":"Maternal and fetal outcomes following exposure to duloxetine in pregnancy: cohort study","volume":"368","author":"KF Huybrechts","year":"2020","journal-title":"BMJ"},{"issue":"1","key":"pmed.1003851.ref033","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/bcpt.12497","article-title":"First-Trimester Pregnancy Exposure to Venlafaxine or Duloxetine and Risk of Major Congenital Malformations: A Systematic Review","volume":"118","author":"D Lassen","year":"2016","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"pmed.1003851.ref034","volume-title":"Title: \u201cObservational Study to Assess Maternal and Fetal Outcomes Following Exposure to Duloxetine\u201d","author":"EnCEPP study registration\u2014Protocol and full study report"},{"issue":"3","key":"pmed.1003851.ref035","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s40801-021-00252-9","article-title":"Duloxetine Exposure During Pregnancy and the Risk of Spontaneous and Elective Abortion: A Danish Nationwide Observational Study","volume":"8","author":"MZ Ankarfeldt","year":"2021","journal-title":"Drugs Real World Outcomes"},{"issue":"7 Suppl","key":"pmed.1003851.ref036","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1403494810394717","article-title":"The Danish National Prescription Registry","volume":"39","author":"HW Kildemoes","year":"2011","journal-title":"Scand J Public Health"},{"issue":"4","key":"pmed.1003851.ref037","first-page":"445","article-title":"The Danish prescription registries","volume":"44","author":"D Gaist","year":"1997","journal-title":"DanMedBull"},{"issue":"7","key":"pmed.1003851.ref038","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/pds.1294","article-title":"The new Swedish Prescribed Drug Register\u2013opportunities for pharmacoepidemiological research and experience from the first six months","volume":"16","author":"B Wettermark","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"pmed.1003851.ref039","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish national inpatient register","volume":"11","author":"JF Ludvigsson","year":"2011","journal-title":"BMC Public Health"},{"issue":"3","key":"pmed.1003851.ref040","first-page":"263","article-title":"The Danish National Hospital Register. A valuable source of data for modern health sciences","volume":"46","author":"TF Andersen","year":"1999","journal-title":"Dan Med Bull"},{"issue":"8","key":"pmed.1003851.ref041","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/0895-4356(96)00018-2","article-title":"Validation of the Danish Birth Registration","volume":"49","author":"J Kristensen","year":"1996","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"pmed.1003851.ref042","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/aogs.12302","article-title":"The Nordic medical birth registers\u2014a potential goldmine for clinical research","volume":"93","author":"J Langhoff-Roos","year":"2014","journal-title":"Acta Obstet Gynecol Scand"},{"key":"pmed.1003851.ref043","unstructured":"Centre for Epidemiology, National Board of Health and Welfare. The Swedish Medical Birth Register: A Summary of Content and Quality. 2003. Available from: https:\/\/www.socialstyrelsen.se\/globalassets\/sharepoint-dokument\/artikelkatalog\/ovrigt\/2003-112-3_20031123.pdf."},{"issue":"7 Suppl","key":"pmed.1003851.ref044","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/1403494811405098","article-title":"Danish registers on personal income and transfer payments","volume":"39","author":"M Baadsgaard","year":"2011","journal-title":"Scand J Public Health"},{"issue":"7 Suppl","key":"pmed.1003851.ref045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/1403494810394715","article-title":"Danish Education Registers","volume":"39","author":"VM Jensen","year":"2011","journal-title":"Scand J Public Health"},{"issue":"9","key":"pmed.1003851.ref046","doi-asserted-by":"crossref","first-page":"E310","DOI":"10.1503\/cmaj.109-4713","article-title":"Sweden\u2019s health data goldmine","volume":"186","author":"PC Webster","year":"2014","journal-title":"CMAJ"},{"key":"pmed.1003851.ref047","unstructured":"European network of population-based registries for the epidemiological surveillance of congenital anomalies (EUROCAT). Classification of congenital malformations version 1.4. [cited 2021 Oct 5]. Available from: https:\/\/eu-rd-platform.jrc.ec.europa.eu\/sites\/default\/files\/Full_Guide_1_4_version_28_DEC2018.pdf."},{"issue":"1","key":"pmed.1003851.ref048","first-page":"29","article-title":"Monitoring perinatal mortality and perinatal care with a national register: content and usage of the Danish Medical Birth Register","volume":"8","author":"LB Knudsen","year":"1986","journal-title":"Community Med"},{"key":"pmed.1003851.ref049","first-page":"165","volume-title":"Performing a 1:N Case-Control Match on Propensity Score","author":"LS Parsons","year":"2004"},{"key":"pmed.1003851.ref050","first-page":"335","volume-title":"A unified approach to measuring the effect size between two groups using SAS","author":"D Yang","year":"2012"},{"key":"pmed.1003851.ref051","unstructured":"WHOCC\u2014WHO Collaborating Centre for Drug Statistics Methodology. [cited 2019 Oct 25]. Available from: https:\/\/www.whocc.no\/."},{"issue":"9","key":"pmed.1003851.ref052","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s40261-013-0112-y","article-title":"Infant health and neurodevelopmental outcomes following prenatal exposure to duloxetine","volume":"33","author":"C Bellantuono","year":"2013","journal-title":"Clin Drug Investig"},{"issue":"2","key":"pmed.1003851.ref053","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00737-011-0215-5","article-title":"Duloxetine transfer across the placenta during pregnancy and into milk during lactation","volume":"14","author":"PM Boyce","year":"2011","journal-title":"Arch Womens Ment Health"},{"issue":"3","key":"pmed.1003851.ref054","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/hup.2473","article-title":"The safety of serotonin-noradrenaline reuptake inhibitors (SNRIs) in pregnancy and breastfeeding: a comprehensive review: SNRIs in Pregnancy and Breastfeeding","volume":"30","author":"C Bellantuono","year":"2015","journal-title":"Hum Psychopharmacol"},{"issue":"6","key":"pmed.1003851.ref055","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/jcp.0b013e31815ac4d2","article-title":"Delivery Outcome in Relation to Maternal Use of Some Recently Introduced Antidepressants","volume":"27","author":"RM Lennestal","year":"2007","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"pmed.1003851.ref056","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/14034940210134194","article-title":"Predictive value and completeness of the registration of congenital abnormalities in three Danish population-based registries","volume":"31","author":"H Larsen","year":"2003","journal-title":"Scand J Public Health"},{"key":"pmed.1003851.ref057","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2147\/CLEP.S15627","article-title":"Children diagnosed with congenital cardiac malformations at the national university departments of pediatric cardiology: positive predictive values of data in the Danish National Patient Registry","volume":"3","author":"P Agergaard","year":"2011","journal-title":"Clin Epidemiol"},{"key":"pmed.1003851.ref058","unstructured":"medstat.dk\u2014statistics of medication use in Denmark. [cited 2019 Oct 25]. Available from: http:\/\/medstat.dk\/."},{"issue":"4","key":"pmed.1003851.ref059","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/AOG.0000000000000447","article-title":"Exposure to selective serotonin reuptake inhibitors in early pregnancy and the risk of miscarriage","volume":"124","author":"JT Andersen","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"5","key":"pmed.1003851.ref060","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/0002-9378(89)90170-1","article-title":"Depressive symptoms during pregnancy: relationship to poor health behaviors","volume":"160","author":"B Zuckerman","year":"1989","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"pmed.1003851.ref061","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00737-014-0470-3","article-title":"The relationship between maternal depression and smoking cessation during pregnancy\u2013a cross-sectional study of pregnant women from 15 European countries","volume":"18","author":"J Smedberg","year":"2015","journal-title":"Arch Womens Ment Health"}],"updated-by":[{"DOI":"10.1371\/journal.pmed.1003851","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T00:00:00Z","timestamp":1638921600000}}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1003851","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,12]],"date-time":"2023-11-12T23:54:03Z","timestamp":1699833243000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1003851"}},"subtitle":[],"editor":[{"given":"Jenny E.","family":"Myers","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,11,22]]},"references-count":61,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1003851","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pmed.1003851","asserted-by":"object"}]},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,22]]}}}